Post-treatment Effects of Erythropoietin and Nordihydroguaiaretic Acid on Recovery from Cisplatin-induced Acute Renal Failure in the Rat

5-Lipoxygenase inhibitor and human recombinant erythropoietin might accelerate renal recovery in cisplatin-induced acute renal failure rats. Male Sprague-Dawley rats were randomized into four groups: 1) normal controls; 2) Cisplatin group-cisplatin induced acute renal failure (ARF) plus vehicle treatment; 3) Cisplatin+nordihydroguaiaretic acid (NDGA) group-cisplatin induced ARF plus 5-lipoxygenase inhibitor treatment; 4) Cisplatin+erythropoietin (EPO) group-cisplatin induced ARF plus erythropoietin treatment. On day 10 (after 7 daily injections of NDGA or EPO), urea nitrogen and serum Cr concentrations were significantly lower in the Cisplatin+NDGA and Cisplatin+EPO groups than in the Cisplatin group, and 24 hr urine Cr clearances were significantly higher in the Cisplatin+EPO group than in the Cisplatin group. Semi-quantitative assessments of histological lesions did not produce any significant differences between the three treatment groups. Numbers of PCNA(+) cells were significantly higher in Cisplatin, Cisplatin+NDGA, and Cisplatin+EPO groups than in normal controls. Those PCNA(+) cells were significantly increased in Cisplatin+NDGA group. These results suggest that EPO and also NDGA accelerate renal function recovery by stimulating tubular epithelial cell regeneration.

[1]  J. Bonventre,et al.  Acute renal failure. , 2018, The New England journal of medicine.

[2]  K. Chopra,et al.  Nordihydroguairetic Acid, a Lignin, Prevents Oxidative Stress and the Development of Diabetic Nephropathy in Rats , 2004, Pharmacology.

[3]  T. Adrian,et al.  The role of eicosanoids in the process of adaptation following massive bowel resection in the rat. , 2001, JPEN. Journal of parenteral and enteral nutrition.

[4]  F. Ezberci,et al.  Protective Effect of a Lipoxygenase Inhibitor, Nordihydroguaretic Acid, on the Ileal Motor Disturbances Induced by Serratia marcescens Endotoxin in Rats , 2001, Surgery Today.

[5]  C. Bagnis,et al.  Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  P. Szapary.  Tyler's Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies , 2000, Annals of Internal Medicine.

[7]  Y. Miura,et al.  Recombinant human erythropoietin at high doses stimulates thrombopoiesis: Treatment for protracted severe myelosuppression complicating interferon‐α and busulfan therapy for chronic myelogenous leukaemia , 1995 .

[8]  J. Haskins,et al.  Critical subcellular targets of cisplatin and related platinum analogs in rat renal proximal tubule cells. , 1995, Kidney international.

[9]  R. Weichselbaum,et al.  Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents , 1995, Nature.

[10]  R. Carlini,et al.  Recombinant human erythropoietin stimulates angiogenesis in vitro. , 1995, Kidney international.

[11]  Tumanovs'ka Lv,et al.  The correction of disorders in arachidonic acid metabolism in coronary spasm of an immune origin , 1994 .

[12]  A. Anagnostou,et al.  Erythropoietin receptor mRNA expression in human endothelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Nagai.  [Effects of rHuEPO on cellular proliferation and endothelin-1 production in cultured endothelial cells]. , 1994, Nihon Jinzo Gakkai shi.

[14]  K. Propert,et al.  A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. , 1990, The New England journal of medicine.

[15]  A. Anagnostou,et al.  Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Gullans,et al.  Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules. , 1990, The American journal of physiology.

[17]  M. Winkelman.  Ethnobotanical treatments of diabetes in Baja California Norte. , 1989, Medical anthropology.

[18]  T. Ozawa,et al.  Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. , 1989, Biochemical and biophysical research communications.

[19]  P. Daley-Yates,et al.  A study of the protective effect of chloride salts on cisplatin nephrotoxicity. , 1985, Biochemical pharmacology.

[20]  R. Branch,et al.  Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[21]  P. Loehrer,et al.  Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.

[22]  J. B. Hill,et al.  Renal and electrolyte disturbances associated with cisplatin. , 1981, Annals of internal medicine.

[23]  Tom J. Mabry,et al.  Creosote bush. Biology and chemistry of Larrea in New World deserts. , 1978 .

[24]  W. Whitmore,et al.  Improvement of Cis‐dichlorodiammineplatinum (NSC 119875): Therapeutic index in an animal model , 1977, Cancer.

[25]  E. Goldwasser,et al.  Role of the Kidney in Erythropoiesis , 1957, Nature.

[26]  W. Keane,et al.  Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. , 2001, Kidney international.

[27]  J. Brent.  Three new herbal hepatotoxic syndromes. , 1999, Journal of toxicology. Clinical toxicology.

[28]  Y. Miura,et al.  Recombinant human erythropoietin at high doses stimulates thrombopoiesis: treatment for protracted severe myelosuppression complicating interferon-alpha and busulfan therapy for chronic myelogenous leukaemia. , 1995, European journal of haematology.

[29]  L. V. Tumanovs'ka,et al.  [The correction of disorders in arachidonic acid metabolism in coronary spasm of an immune origin]. , 1994, Fiziolohichnyi zhurnal.

[30]  M. Berridge,et al.  Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. , 1989, Experimental hematology.